World Wires · story 50770 · official · 1 source(s)

SCHEDULE 13D: SV Biotech Crossover Opportunities Fund LP discloses a stake in TRex Bio, Inc.

Filed: 2026-10-16 AccNo: 0001829126-26-011242 Size: 51 KB

Open in the desk

Coverage

• SCHEDULE 13D: SV Biotech Crossover Opportunities Fund LP discloses a stake in TRex Bio, Inc. SEC EDGAR: Schedule 13D stakes · tier A · clear net · 2026-10-16 19:53 UTC

What this site indexes